1. Brazil Stocks

  2. •

    Health services

  3. •

    Medical/Nursing services
Diagnosticos da America S.A.

Diagnosticos da America S.A.

5.12
BRL
-0.42
(-7.58%)
-0.70EPS
3.39BMarket Cap
Nov 05Next Earn
Diagnosticos da America S.A.
B3:DASA3F
(B3)

Recent

price

5.12

P/E

ratio

- -

div

yld

0.08%

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
BRL
6.55
7.02
7.29
7.88
8.68
8.99
9.78
10.9
12.61
13.86
14.64
18.59
23.52
19.08
12.26
8.94
7.45
Revenue per Share
0.43
0.47
0.27
0.42
0.26
0.08
0.3
0.42
0.59
0.4
-0.31
-0.4
-0.69
-1.56
-0.96
-0.92
-0.72
Basic EPS, GAAP
0.3
0.03
0.23
0.36
0.81
0.77
1.65
1.28
0.74
0.62
0.02
0.7
-2.09
-2.38
-0.41
-0.26
0.2
Free Cash Flow per Basic Share
0.1
0.09
0.12
0.07
0.1
0.06
0.07
0.12
0.56
0.5
0.43
0.39
0.29
- -
0.01
- -
- -
Dividend per Share
2.68
8.18
8.39
8.72
8.92
8.97
9.2
10.69
10.7
10.39
7.36
13.46
12.68
9.81
6.34
5.49
5.47
Book Value per Share
0.81
0.58
0.83
1.21
1.36
1.46
0.72
-0.19
-0.86
-2.38
-1.94
-3.01
-6.61
-4.56
-1.73
1.98
2.08
Tangible Book Value per Share
229
311
311
311
311
311
311
312
312
315
481
560
558
747
1,250
1,250
1,251
Basic Weighted Avg Shares
1,502
2,180
2,264
2,448
2,698
2,794
3,041
3,399
3,933
4,365
7,039
10,419
13,129
14,252
15,322
11,170
9,324
Sales/Revenue/Turnover
19.54
17.18
10.82
11.76
9.22
5.64
9.87
9.89
8.97
9.01
1.88
0.85
7.98
6.4
6.57
9.06
7.66
Operating Margin (%)
91
126
153
145
170
186
229
227
260
456
766
930
1,112
1,296
1,367
1,123
963
Depreciation Expense
98
145
85
131
82
24
95
131
184
125
-151
-227
-387
-1,166
-1,199
-1,152
-895
Net Income, GAAP
30.07
31.12
35.45
35.27
40.21
54.6
51.27
25.52
4.5
6.06
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
6.52
6.67
3.76
5.36
3.05
0.85
3.12
3.87
4.69
2.86
-2.14
-2.17
-2.95
-8.18
-7.83
-10.31
-9.6
Profit Margin (%)
160
413
592
708
618
604
580
83
884
712
1,198
-82
1,556
1,390
2,904
1,091
921
Working Capital
402
798
987
1,054
795
895
972
1,120
2,096
3,392
6,051
6,971
11,798
11,397
11,712
6,486
5,760
LT Debt
615
2,542
2,607
2,709
2,772
2,790
2,861
3,320
3,321
3,263
3,537
7,549
7,089
7,334
7,936
6,893
6,866
Total Equity
14.99
10.27
4.38
4.75
3.61
1.77
3.52
5.32
6.06
5.7
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
26.82
10.49
4.36
5.78
4.45
2.85
4.54
5.71
6.11
5.85
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
16.77
9.21
3.31
4.94
3
0.86
3.35
4.24
5.53
3.78
-4.43
-4.09
-5.29
-16.18
-15.72
-15.58
-12.39
Return on Common Equity (%)

Capital Structure

BRL

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
2,356
1,691
1,616
LT Borrowings
5,732
5,738
5,068
LT Finance Leases
753
708
692
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,250
1,250
1,250
Market Capitalization
5,736
3,637
3,387

Working Capital

BRL

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
5,654
5,023
4,356
Cash, Cash Equivalents & STI
2,665
1,705
959
Accounts Receivable, Net
2,101
2,377
2,406
Inventories
190
175
169
Total Current Liabilities
4,563
3,854
3,434
Payables & Accruals
- -
- -
- -
ST Debt
2,356
1,691
1,616
Deferred Revenue
- -
- -
- -

Growth Rates

BRL

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
13.11%
21.18%
-13.14%
Free Cash Flow
302.94%
618.2%
-36.02%
Net Income, GAAP
44.49%
64.26%
-3.92%
Sales/Revenue/Turnover
17.15%
12.6%
-27.1%
Total Cash Common Dividend
- -
- -
-50.24%

Quarterly Revenue

BRL

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
3,728
3,956
3,969
3,669
15,322
2025
3,826
2,466
2,608
2,270
11,170
2026
2,223
2,224
- -
- -
- -

Quarterly Earnings Per Share

BRL

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.24
-0.14
-0.12
-0.66
-0.96
2025
-0.09
-0.14
0.08
-0.76
-0.92
2026
- -
-0.03
- -
- -
- -

Quarterly Dividends Per Share

BRL

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.01
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Hims & Hers Health, Inc. (NYSE:HIMS)
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
Mobile-health Network Solutions (NASDAQ:MNDR)
Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
Tenon Medical, Inc. (NASDAQ:TNON)
Teladoc Health, Inc. (NYSE:TDOC)
Business
Diagnósticos da América S.A. (DASA3.SA) operates as a leading provider of diagnostic medicine and hospital services in Latin America. The company offers clinical analysis and diagnostic imaging tests through approximately 3,000 types of examinations; outpatient care and care coordination services including remote monitoring, population health management, home medical care, and paramedical services; hospital and oncology services encompassing medical consultations and inpatient treatment; laboratory support for small and medium-sized labs under the Alvaro brand; public health sector diagnostics via CientíficaLab; and international diagnostics in Argentina, Uruguay, Chile, and Colombia. It serves private patients, partner companies, public hospitals, and healthcare facilities primarily in Brazil and South America under brands such as Delboni Auriemo, Lavoisier, Alta, Leforte, and Christóvão da Gama. Founded in 1961 and headquartered in Barueri, Greater São Paulo, Brazil, Diagnósticos da América competes with firms like Fleury, Amil, and Rede D'Or in the diagnostics and hospital sectors. In 2024, the company formed a 50/50 joint venture with Amil to combine hospital operations, creating Brazil's largest operator-free hospital platform with 25 hospitals and oncology clinics; it also pursued asset sales outside the JV and reported strong Q3 2025 growth with revenue increases and operational cash flow improvements.